{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-127038","form_type":"8-K","ticker":"KZR","cik":"0001645666","company_name":"Kezar Life Sciences, Inc.","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.091627+00:00","generated_at":"2026-05-30T00:29:55.777892+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Kezar Life Sciences regains Nasdaq compliance as stock price holds above $1.00","bullets":["Received Nasdaq Staff letter on Nov 13, 2024 confirming regained compliance.","Closing bid price was $1.00 or greater for 10 consecutive business days through Nov 13.","Now compliant with Nasdaq Listing Rule 5550(a)(2) minimum bid price requirement.","Resolves prior deficiency; no further action required from the company."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-127038","json":"https://secwatch.observer/filing/0000950170-24-127038.json","markdown":"https://secwatch.observer/filing/0000950170-24-127038.md","text":"https://secwatch.observer/filing/0000950170-24-127038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645666/000095017024127038/0000950170-24-127038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645666/000095017024127038/kzr-20241113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:29:55.777892+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}